Fertility Testing at NYU Langone Reproductive Specialists of New York | NYU Langone Health
Doctors at NYU Langone Reproductive Specialists of New York use fertility testing to determine the cause of infertility.
Fertility Wellness Program | NYU Langone Health
NYU Langone’s Fertility Center has many classes and services available to help you manage stress and prepare your body for pregnancy.
Ferumoxytol-enhanced MRI of Cerebrovascular Diseases
The purpose of this research study is to assess new magnetic resonance imaging methods and a new contrast agent for the evaluation of cerebrovascular diseases. It is hoped that these techniques will enable researchers and clinicians to better detect cerebrovascular diseases. The images collected of the brains of patients with cerebrovascular diseases will be compared to the images from healthy volunteers to assess the technique and agent's sensitivity.
Fetal Cardiac and Brain Magnetic Resonance Imaging during Pregnancy
This will be an observational study to implement a standardized fetal magnetic resonance imaging program targeted to imaging the fetal heart, brain and placenta. The study will initially focus on patients without congenital anomalies. The second phase will image patients with brain or cardiac anomalies. The goal is to have sufficient imaging quality by the end of the study to begin a clinical program.
Fetal Diagnosis & Treatment Program | NYU Langone Health
Experts at NYU Langone’s Fetal Diagnosis and Treatment Program provide pregnant women and their babies with advanced medical care.
Fetal Diagnosis & Treatment Program Doctors | NYU Langone Health
Find a doctor at the Fetal Diagnosis & Treatment Program at NYU Langone.
Fetal Diagnosis & Treatment Program Specialists | NYU Langone Health
Specialists at NYU Langone’s Fetal Diagnosis and Treatment Program provide expert care for your baby before and after birth.
Fetal Heart Disease Program | NYU Langone Health
At the Fetal Heart Disease Program, part of Hassenfeld Children’s Hospital at NYU Langone, we treat heart defects in unborn babies.
Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations (IND 156083)
A Phase II randomized trial will be initiated to evaluate efficacy of FGF-2 in treatment of chronic non-healing tympanic membrane perforation.This study is a double blinded, placebo-controlled phase II study evaluating the efficacy of FGF-2 for the treatment of chronic non-healing tympanic membrane perforations (TMP). The documentation of TM closure will be the main efficacy outcome measure. Pretreatment photographs will document the area of the TM perforation and allow measurement of surface areas of the TMP for comparison of pre- and post-treatment. The study will be divided into two phases, the Randomized Treatment phase (part A), and the Unblinded Crossover phase (part B). In part A of the study, subjects will be randomized 1:1 to receive FGF-2 or placebo treatment up to 3 treatments. Subjects that fail three study treatments will move on to part B of the study. Subjects who received placebo in part A and failed three placebo treatments will crossover to receive unblinded FGF-2 for up to 3 treatments. Subjects who received FGF-2 in part A and failed three experimental treatments will not have additional FGF-2 treatment, and will move on to study follow up.
Fibroids | NYU Langone Health
Doctors at NYU Langone are specialists in treating women with fibroids, which are noncancerous growths in the uterus.